Novartis expands generics range for $8.4 billion
Article Abstract:
Switzerland's Novartis AG is to acquire Hexal AG of Germany and Eon Labs Inc. of the United States for a total of approximately $8.4 billion giving Novartis AG weight in the international pharmaceutical industry which may lead to more consolidations in generics.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
Germany, Commodity & service prices, Securities issued, listed, Security brokers and dealers, Securities & Commodities Services, Securities, Commodity Contracts, and Other Financial Investments and Related Activities, Industry Overview, Prices and rates, Securities industry, Securities, Company securities, Company pricing policy, Eon Labs Inc., Hexal AG
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Shareholder insurrection infects Novartis's $5.1 billion Chiron bid
Article Abstract:
Novartis AG of Switzerland is to acquire the 58 percent of Chiron Corp. of th United States it doesn't already own for $5.1 billion. However, two of Chiron Corp.'s major shareholders have said the deal is too low.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
Financial management, Investor relations, Chiron Corp., CHIR, Company overview
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Pharmaceutical industry, Mergers, acquisitions and divestments, Company acquisition/merger, Switzerland, Novartis AG, NVTSY
Similar abstracts:
- Abstracts: Novartis AG. Novartis suffers another setback for Prexige debut
- Abstracts: Roche's net rises strongly, buoyed by cancer drugs. Novartis buys American rights to antidepressant
- Abstracts: A play of spaces. History revision. Complementary health
- Abstracts: 4 surprising causes of GI distress. Diets don't work for you? Always tired?
- Abstracts: Irish deep water ship almost ready. International gear training set to grow. Irish multi - purpose research vessel
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.